In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions ...

Across hundreds of published papers, CBER’s new chief has argued for more stringent measures of assessing drugs for cancer ...

The US Food and Drug Administration has chosen Dr Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...

The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...

In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...

The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...

The U.S. FDA has appointed Vinay Prasad to be the next director of its Center for Biologics Evaluation and Research division ...